Medaphor Group PLC AGM Statement (3520O)
May 17 2018 - 1:01AM
UK Regulatory
TIDMMED
RNS Number : 3520O
Medaphor Group PLC
17 May 2018
MedaPhor Group plc
("MedaPhor" or the "Group" or the "Company")
AGM Statement
MedaPhor Group plc (AIM: MED), the intelligent ultrasound
software and simulation company, will hold its Annual General
Meeting today at 10.30 a.m. at IP Group Offices, The Walbrook
Building, 25 Walbrook, London, EC4N 8AF. At the meeting the
Chairman, Riccardo Pigliucci, will make the following
statement:
"The Group is trading in line with management's expectations,
research and development work being undertaken by our Clinical
Division is progressing well and Simulation Division sales in the
UK and mainland Europe are showing good signs of recovery. Initial
orders placed in our key territories for our recently launched
BodyWorks point of care and emergency medicine simulator are also
encouraging."
A copy of this announcement is available on the Group's website:
www.medaphor.com
MedaPhor Group plc www.medaphor.com
Stuart Gall, CEO Tel: +44 (0)29 2075
Ian Whittaker, COO 6534
Cenkos Securities Tel: +44 (0)20 7397
8900
Camilla Hume (Nominated Advisor)
Michael Johnson / Julian
Morse (Corporate Broking)
Walbrook PR Tel: +44 (0)20 7933 8780 or
medaphor@walbrookpr.com
Paul McManus / Anna Mob: +44 (0)7980 541 893 / Mob:
Dunphy +44 (0)7876 741 001
About MedaPhor (www.investors.medaphor.com)
MedaPhor (AIM: MED), the intelligent ultrasound software and
simulation company, develops artificial intelligence-based clinical
image analysis software tools, augmented reality-based needle
guidance software and advanced hi-fidelity haptic and manikin-based
training simulators for medical practitioners.
Based in Cardiff and Oxford in the UK and Atlanta in the US and
Hong Kong in Asia, MedaPhor operates two divisions:
Intelligent Ultrasound Simulation Division
Focuses on hi-fidelity ultrasound education and training through
simulation. Its three main products are the ScanTrainer OBGYN and
General Medical simulator training platform, the HeartWorks
echocardiography simulator platform and the BodyWorks Eve Point of
Care and Emergency Medicine Simulator. Over 500 MedaPhor simulators
have been sold to over 300 medical institutions in over 30
countries around the world.
Intelligent Ultrasound Clinical Division
Focuses on augmented reality and deep-learning based algorithms
to make ultrasound machines smarter and more accessible. Products
in development include ScanNav and NeedleGuide. ScanNav uses
machine-learning based algorithms to automatically identify, grade
and capture good ultrasound images. NeedleGuide aims to simplify
ultrasound-guided needling by using deep learning and augmented
reality to provide the user with pathway guidance and automated
tracking for a range of medical procedures.
Some products in the pipeline may require US FDA approval, as
such this material should be considered informational only and does
not constitute an offer to sell or infer claims or benefits.
This information is provided by RNS
The company news service from the London Stock Exchange
END
AGMUNRURWSAVAUR
(END) Dow Jones Newswires
May 17, 2018 02:01 ET (06:01 GMT)
Intelligent Ultrasound (LSE:IUG)
Historical Stock Chart
From Apr 2024 to May 2024
Intelligent Ultrasound (LSE:IUG)
Historical Stock Chart
From May 2023 to May 2024